Literature DB >> 28842941

Characterization of early communicative behavior in mouse models of neurofibromatosis type 1.

Susan E Maloney1,2, Krystal C Chandler1,2, Corina Anastasaki3, Michael A Rieger1,2, David H Gutmann3, Joseph D Dougherty1.   

Abstract

Neurofibromatosis type 1 (NF1) is a monogenic neurodevelopmental disease caused by germline loss-of-function mutations in the NF1 tumor suppressor gene. Cognitive impairments are observed in approximately 80% of children with this disease, with 45-60% exhibiting autism spectrum disorder (ASD) symptomatology. In light of the high comorbidity rate between ASD and NF1, we assessed early communicative behavior by maternal-separation induced pup ultrasonic vocalizations (USV) and developmental milestones in two distinct Nf1 genetically engineered models, one modeling clinical germline heterozygous loss of Nf1 function (Nf1+/- mice), and a second with somatic biallelic Nf1 inactivation in neuroglial progenitor cells (Nf1GFAP CKO mice). We observed altered USV production in both models: Nf1+/- mice exhibited both increased USVs across development and alterations in aspects of pitch, while Nf1GFAP CKO mice demonstrated a decrease in USVs. Developmental milestones, such as weight, pinnae detachment, and eye opening, were not disrupted in either model, indicating the USV deficits were not due to gross developmental delay, and likely reflected more specific alterations in USV circuitry. In this respect, increased whole-brain serotonin was observed in Nf1+/- mice, but whole-brain levels of dopamine and its metabolites were unchanged at the age of peak USV disruption, and USV alterations did not correlate with overall level of neurofibromin loss. The early communicative phenotypes reported herein should motivate further studies into the risks mediated by haploinsufficiency and biallelic deletion of Nf1 across a full battery of ASD-relevant behavioral phenotypes, and a targeted analysis of underlying circuitry disruptions. Autism Res 2018, 11: 44-58.
© 2017 International Society for Autism Research, Wiley Periodicals, Inc. LAY SUMMARY: Neurofibromatosis type 1 (NF1) is a common neurogenetic disorder caused by mutation of the NF1 gene, in which 80% of affected children exhibit cognitive and behavioral issues. Based on emerging evidence that NF1 may be an autism predisposition gene, we examined autism spectrum disorder (ASD)-relevant early communicative behavior in Nf1 mouse models and observed alterations in both models. The changes in early communicative behavior in Nf1 mutant mice should motivate further studies into the causative factors and potential treatments for ASD arising in the context of NF1. © 2017 International Society for Autism Research, Wiley Periodicals, Inc.

Entities:  

Keywords:  autism; communication; mouse; neurofibromatosis type 1; ultrasonic vocalization

Mesh:

Year:  2017        PMID: 28842941      PMCID: PMC5773379          DOI: 10.1002/aur.1853

Source DB:  PubMed          Journal:  Autism Res        ISSN: 1939-3806            Impact factor:   5.216


  62 in total

1.  Pharmacological inhibition of Anaplastic Lymphoma Kinase rescues spatial memory impairments in Neurofibromatosis 1 mutant mice.

Authors:  Joseph B Weiss; Sydney Weber; Tessa Marzulla; Jacob Raber
Journal:  Behav Brain Res       Date:  2017-06-16       Impact factor: 3.332

2.  Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1.

Authors:  Karin S Walsh; Jorge I Vélez; Peter G Kardel; Daniel M Imas; Maximilian Muenke; Roger J Packer; Francisco X Castellanos; Maria T Acosta
Journal:  Dev Med Child Neurol       Date:  2012-11-16       Impact factor: 5.449

Review 3.  The pathoetiology of neurofibromatosis 1.

Authors:  Eeva-Mari Jouhilahti; Sirkku Peltonen; Anthony M Heape; Juha Peltonen
Journal:  Am J Pathol       Date:  2011-03-31       Impact factor: 4.307

4.  Neurofibromatosis type 1 and autism spectrum disorder.

Authors:  Shruti Garg; Jonathan Green; Kathy Leadbitter; Richard Emsley; Annukka Lehtonen; D Gareth Evans; Susan M Huson
Journal:  Pediatrics       Date:  2013-11-04       Impact factor: 7.124

5.  Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues.

Authors:  C I Brannan; A S Perkins; K S Vogel; N Ratner; M L Nordlund; S W Reid; A M Buchberg; N A Jenkins; L F Parada; N G Copeland
Journal:  Genes Dev       Date:  1994-05-01       Impact factor: 11.361

6.  The disruption of Celf6, a gene identified by translational profiling of serotonergic neurons, results in autism-related behaviors.

Authors:  Joseph D Dougherty; Susan E Maloney; David F Wozniak; Michael A Rieger; Lisa Sonnenblick; Giovanni Coppola; Nathaniel G Mahieu; Juliet Zhang; Jinlu Cai; Gary J Patti; Brett S Abrahams; Daniel H Geschwind; Nathaniel Heintz
Journal:  J Neurosci       Date:  2013-02-13       Impact factor: 6.167

7.  Brain and behaviour phenotyping of a mouse model of neurofibromatosis type-1: an MRI/DTI study on social cognition.

Authors:  L I Petrella; Y Cai; J V Sereno; S I Gonçalves; A J Silva; M Castelo-Branco
Journal:  Genes Brain Behav       Date:  2016-07-05       Impact factor: 3.449

Review 8.  Clinical and genetic aspects of neurofibromatosis 1.

Authors:  Kimberly Jett; Jan M Friedman
Journal:  Genet Med       Date:  2010-01       Impact factor: 8.822

9.  Analysis of within Subjects Variability in Mouse Ultrasonic Vocalization: Pups Exhibit Inconsistent, State-Like Patterns of Call Production.

Authors:  Michael A Rieger; Joseph D Dougherty
Journal:  Front Behav Neurosci       Date:  2016-09-28       Impact factor: 3.558

10.  Of mice, birds, and men: the mouse ultrasonic song system has some features similar to humans and song-learning birds.

Authors:  Gustavo Arriaga; Eric P Zhou; Erich D Jarvis
Journal:  PLoS One       Date:  2012-10-10       Impact factor: 3.240

View more
  14 in total

Review 1.  An update on the central nervous system manifestations of neurofibromatosis type 1.

Authors:  J Stephen Nix; Jaishri Blakeley; Fausto J Rodriguez
Journal:  Acta Neuropathol       Date:  2019-04-08       Impact factor: 17.088

2.  Neurofibromatosis Type 1 Implicates Ras Pathways in the Genetic Architecture of Neurodevelopmental Disorders.

Authors:  Jessica A Kaczorowski; Taylor F Smith; Amanda M Shrewsbury; Leah R Thomas; Valerie S Knopik; Maria T Acosta
Journal:  Behav Genet       Date:  2020-02-05       Impact factor: 2.805

3.  Gtf2i and Gtf2ird1 mutation do not account for the full phenotypic effect of the Williams syndrome critical region in mouse models.

Authors:  Nathan Kopp; Katherine McCullough; Susan E Maloney; Joseph D Dougherty
Journal:  Hum Mol Genet       Date:  2019-10-15       Impact factor: 6.150

4.  A MYT1L syndrome mouse model recapitulates patient phenotypes and reveals altered brain development due to disrupted neuronal maturation.

Authors:  Jiayang Chen; Mary E Lambo; Xia Ge; Joshua T Dearborn; Yating Liu; Katherine B McCullough; Raylynn G Swift; Dora R Tabachnick; Lucy Tian; Kevin Noguchi; Joel R Garbow; John N Constantino; Harrison W Gabel; Keith B Hengen; Susan E Maloney; Joseph D Dougherty
Journal:  Neuron       Date:  2021-10-05       Impact factor: 17.173

5.  Using animal models to evaluate the functional consequences of anesthesia during early neurodevelopment.

Authors:  Susan E Maloney; Catherine E Creeley; Richard E Hartman; Carla M Yuede; Charles F Zorumski; Vesna Jevtovic-Todorovic; Krikor Dikranian; Kevin K Noguchi; Nuri B Farber; David F Wozniak
Journal:  Neurobiol Learn Mem       Date:  2018-03-14       Impact factor: 2.877

6.  Examining the Reversibility of Long-Term Behavioral Disruptions in Progeny of Maternal SSRI Exposure.

Authors:  Susan E Maloney; Shyam Akula; Michael A Rieger; Katherine B McCullough; Krystal Chandler; Adrian M Corbett; Audrey E McGowin; Joseph D Dougherty
Journal:  eNeuro       Date:  2018-07-09

Review 7.  An executive functioning perspective in neurofibromatosis type 1: from ADHD and autism spectrum disorder to research domains.

Authors:  Taylor F Smith; Jessica A Kaczorowski; Maria T Acosta
Journal:  Childs Nerv Syst       Date:  2020-07-03       Impact factor: 1.475

8.  NF1-cAMP signaling dissociates cell type-specific contributions of striatal medium spiny neurons to reward valuation and motor control.

Authors:  Laurie P Sutton; Brian S Muntean; Olga Ostrovskaya; Stefano Zucca; Maria Dao; Cesare Orlandi; Chenghui Song; Keqiang Xie; Kirill A Martemyanov
Journal:  PLoS Biol       Date:  2019-10-10       Impact factor: 8.029

9.  Shared developmental gait disruptions across two mouse models of neurodevelopmental disorders.

Authors:  Joseph D Dougherty; Susan E Maloney; Rachel M Rahn; Claire T Weichselbaum; David H Gutmann
Journal:  J Neurodev Disord       Date:  2021-03-20       Impact factor: 4.074

10.  Ontogenetic Oxycodone Exposure Affects Early Life Communicative Behaviors, Sensorimotor Reflexes, and Weight Trajectory in Mice.

Authors:  Elena Minakova; Simona Sarafinovska; Marwa O Mikati; Kia M Barclay; Katherine B McCullough; Joseph D Dougherty; Ream Al-Hasani; Susan E Maloney
Journal:  Front Behav Neurosci       Date:  2021-02-22       Impact factor: 3.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.